by Jordana Choucair | Feb 23, 2022 | Life Sciences
CDC data shows that COVID-19 vaccines provided weaker protection against the omicron variant than during other surges, leading to higher rates of infection, hospitalization, and death for fully vaccinated and boosted adults. Vaccinated people still fared much better...
by Jordana Choucair | Feb 21, 2022 | Life Sciences
The FDA is “very carefully” considering second booster doses of the mRNA COVID-19 vaccines. According to FDA spokesperson Alison Hunt, the agency is “continually looking at the emerging data on the pandemic and variants in the United States and overseas in...
by Jordana Choucair | Feb 18, 2022 | Life Sciences
The Biden administration will offer more than $250 million in “intensive support” for COVID-19 vaccination in 11 sub-Saharan African countries with low vaccination rates through the Global VAX initiative outlined in December. The funding will support...
by Jordana Choucair | Feb 18, 2022 | Life Sciences
The Federal Trade Commission (FTC) will not move forward with a study examining how pharmacy benefit managers’ (PBMs) controversial business practices affect independent and specialty pharmacies. The commissioners tied in a 2-2 vote over an effort to broaden the...
by Jordana Choucair | Feb 17, 2022 | Life Sciences
White House officials said they’ve shipped 50 million free at-home COVID-19 tests to U.S. households, representing about 85 percent of initial orders, with the rest of the tests to be sent in the coming days. They also said they are working on a plan to...
by Jordana Choucair | Feb 14, 2022 | Life Sciences
The Federal Trade Commission will vote Thursday on whether it will study how pharmacy benefit managers (PBMs) affect drug prices and the businesses of pharmacies. The vote comes after years of pharmacies’ complaints over PBM fees for reimbursement, quality metrics,...
Recent Comments